MANDELLI; Stefano

Patent Applications and Registrations

Patent applications and USPTO patent grants for MANDELLI; Stefano.The latest application filed is for "benzo-and pyrido-pyrazoles as protein kinase inhibitors".

Company Profile

0.10.10

MANDELLI; Stefano - Casatenovo IT
Mandelli; Stefano - Monza IT
Mandelli; Stefano - Casatenovo Lecco
Mandelli; Stefano - Cambiago Milano
Mandelli; Stefano - Cambiago IT
Mandelli, Stefano - Cambiago Malino

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Benzo-and Pyrido-pyrazoles As Protein Kinase Inhibitors App 20220041559 - Rovati; Lucio Claudio ; et al.	2022-02-10
4,4-difluoro-piperidine-compounds Grant 9,493,438 - Stasi , et al. November 15, 2	2016-11-15
Crystalline forms of 6-(1H-imidazol-1-yl)-2-phenylquinazoline Grant 9,174,966 - Giordani , et al. November 3, 2	2015-11-03
Chemical compounds Grant 9,062,033 - Stasi , et al. June 23, 2	2015-06-23
4,4-difluoro-piperidine-compounds App 20150051226 - Stasi; Luigi Piero ; et al.	2015-02-19
Chemical Compounds App 20140357653 - Stasi; Luigi Piero ; et al.	2014-12-04
6-1H-imidazo-quinazoline and quinolines derivatives, new MAO inhibitors and imidazoline receptor ligands Grant 8,633,208 - Giordani , et al. January 21, 2	2014-01-21
Crystalline Forms Of 6-(1h-imidazol-1-yl)-2-phenylquinazoline App 20120142713 - Giordani; Antonio ; et al.	2012-06-07
6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents Grant 8,193,353 - Giordani , et al. June 5, 2	2012-06-05
6-1h-imidazo-quinazoline And Quinolines Derivatives, New Potent Analgesics And Anti-inflammatory Agents App 20110257209 - GIORDANI; Antonio ; et al.	2011-10-20
6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents Grant 7,994,181 - Giordani , et al. August 9, 2	2011-08-09
Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents Grant 7,968,558 - Giordani , et al. June 28, 2	2011-06-28
6-1h-imidazo-quinazoline And Quinolines Derivatives, New Mao Inhibitors And Imidazoline Receptor Ligands App 20110118289 - Giordani; Antonio ; et al.	2011-05-19
Novel Anti-Inflammatory and Analgesic Heterocyclic Amidines that Inhibit Nitrogen Oxide (NO) Production App 20100120802 - MAKOVEC; Francesco ; et al.	2010-05-13
Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production Grant 7,674,809 - Makovec , et al. March 9, 2	2010-03-09
6-1h-imidazo-quinazoline And Quinolines Derivatives, New Potent Analgesics And Anti-inflammatory Agents App 20090264451 - Giordani; Antonio ; et al.	2009-10-22
Amidine Derivatives Of 2-heteroaryl-quinazolines And Quinolines; Potent Analgesics And Anti-inflammatory Agents App 20090227609 - Giordani; Antonio ; et al.	2009-09-10
Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production App 20050197331 - Makovec, Francesco ; et al.	2005-09-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.